印度尼西亚北苏门答腊岛尼亚斯岛人类疟疾的药物敏感性和传播动态

D. Fryauff, B. Leksana, S. Masbar, I. Wiady, P. Sismadi, Augustina I. Susanti, H. Nagesha, Syafruddin, S. Atmosoedjono, M. Bangs, J. Baird
{"title":"印度尼西亚北苏门答腊岛尼亚斯岛人类疟疾的药物敏感性和传播动态","authors":"D. Fryauff, B. Leksana, S. Masbar, I. Wiady, P. Sismadi, Augustina I. Susanti, H. Nagesha, Syafruddin, S. Atmosoedjono, M. Bangs, J. Baird","doi":"10.1179/000349802125001249","DOIUrl":null,"url":null,"abstract":"Abstract Nias Island, off the north-western coast of Sumatra, Indonesia, was one of the first locations in which chloroquine-resistant Plasmodium vivax malaria was reported. This resistance is of particular concern because its ancient megalithic culture and the outstanding surfing conditions make the island a popular tourist destination. International travel to and from the island could rapidly spread chloroquine-resistant strains of P. vivax across the planet. The threat posed by such strains, locally and internationally, has led to the routine and periodic re-assessment of the efficacy of antimalarial drugs and transmission potential on the island. Active case detection identified malaria in 124 (17%) of 710 local residents whereas passive case detection, at the central health clinic, confirmed malaria in 77 (44%) of 173 cases of presumed 'clinical malaria'. Informed consenting volunteers who had malarial parasitaemias were treated, according to the Indonesian Ministry of Health's recommendations, with sulfadoxine-pyrimethamine (SP) on day 0 (for P. falciparum) or with chloroquine (CQ) on days 0, 1 and 2 (for P. vivax). Each volunteer was then monitored for clinical and parasite response until day 28. Recurrent parasitaemia by day 28 treatment was seen in 29 (83%) of the 35 P. falciparum cases given SP (14, 11 and four cases showing RI, RII and RIII resistance, respectively). Recurrent parasitaemia was also observed, between day 11 and day 21, in six (21%) of the 28 P. vivax cases given CQ. Although the results of quantitative analysis confirmed only low prevalences of CQ-resistant P. vivax malaria, the prevalence of SP resistance among the P. falciparum cases was among the highest seen in Indonesia. When the parasites present in the volunteers with P. falciparum infections were genotyped, mutations associated with pyrimethamine resistance were found at high frequency in the dhfr gene but there was no evidence of selection for sulfadoxine resistance in the dhps gene. Night-biting mosquitoes were surveyed by human landing collections and tested for sporozoite infection. Among the five species of human-biting anophelines collected, Anopheles sundaicus was dominant (68%) and the only species found to be infective—two (1.2%) of 167 females being found carrying P. vivax sporozoites. The risk of malarial infection for humans on Nias was considered high because of the abundance of asymptomatic carriers, the reduced effectiveness of the available antimalarial drugs, and the biting and infection 'rates' of the local An. sundaicus.","PeriodicalId":8038,"journal":{"name":"Annals of Tropical Medicine & Parasitology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"40","resultStr":"{\"title\":\"The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia\",\"authors\":\"D. Fryauff, B. Leksana, S. Masbar, I. Wiady, P. Sismadi, Augustina I. Susanti, H. Nagesha, Syafruddin, S. Atmosoedjono, M. Bangs, J. Baird\",\"doi\":\"10.1179/000349802125001249\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract Nias Island, off the north-western coast of Sumatra, Indonesia, was one of the first locations in which chloroquine-resistant Plasmodium vivax malaria was reported. This resistance is of particular concern because its ancient megalithic culture and the outstanding surfing conditions make the island a popular tourist destination. International travel to and from the island could rapidly spread chloroquine-resistant strains of P. vivax across the planet. The threat posed by such strains, locally and internationally, has led to the routine and periodic re-assessment of the efficacy of antimalarial drugs and transmission potential on the island. Active case detection identified malaria in 124 (17%) of 710 local residents whereas passive case detection, at the central health clinic, confirmed malaria in 77 (44%) of 173 cases of presumed 'clinical malaria'. Informed consenting volunteers who had malarial parasitaemias were treated, according to the Indonesian Ministry of Health's recommendations, with sulfadoxine-pyrimethamine (SP) on day 0 (for P. falciparum) or with chloroquine (CQ) on days 0, 1 and 2 (for P. vivax). Each volunteer was then monitored for clinical and parasite response until day 28. Recurrent parasitaemia by day 28 treatment was seen in 29 (83%) of the 35 P. falciparum cases given SP (14, 11 and four cases showing RI, RII and RIII resistance, respectively). Recurrent parasitaemia was also observed, between day 11 and day 21, in six (21%) of the 28 P. vivax cases given CQ. Although the results of quantitative analysis confirmed only low prevalences of CQ-resistant P. vivax malaria, the prevalence of SP resistance among the P. falciparum cases was among the highest seen in Indonesia. When the parasites present in the volunteers with P. falciparum infections were genotyped, mutations associated with pyrimethamine resistance were found at high frequency in the dhfr gene but there was no evidence of selection for sulfadoxine resistance in the dhps gene. Night-biting mosquitoes were surveyed by human landing collections and tested for sporozoite infection. Among the five species of human-biting anophelines collected, Anopheles sundaicus was dominant (68%) and the only species found to be infective—two (1.2%) of 167 females being found carrying P. vivax sporozoites. The risk of malarial infection for humans on Nias was considered high because of the abundance of asymptomatic carriers, the reduced effectiveness of the available antimalarial drugs, and the biting and infection 'rates' of the local An. sundaicus.\",\"PeriodicalId\":8038,\"journal\":{\"name\":\"Annals of Tropical Medicine & Parasitology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"40\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Tropical Medicine & Parasitology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1179/000349802125001249\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Tropical Medicine & Parasitology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1179/000349802125001249","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 40

摘要

印度尼西亚苏门答腊岛西北海岸外的Nias岛是第一批报道氯喹抗性间日疟原虫疟疾的地点之一。这种阻力尤其令人担忧,因为它古老的巨石文化和出色的冲浪条件使该岛成为一个受欢迎的旅游目的地。往返该岛的国际旅行可能会在全球范围内迅速传播抗氯喹的间日疟原虫菌株。由于这些菌株在当地和国际上造成的威胁,必须定期重新评估抗疟药物的效力和在该岛传播的可能性。在710名当地居民中,主动病例检测发现124人(17%)患有疟疾,而在中央卫生诊所,被动病例检测在173例假定的"临床疟疾"病例中确诊77人(44%)患有疟疾。根据印度尼西亚卫生部的建议,患有疟疾寄生虫病的知情同意志愿者在第0天使用磺胺多辛-乙胺嘧啶(SP)(用于恶性疟原虫)或在第0、1和2天使用氯喹(CQ)(用于间日疟原虫)进行治疗。然后监测每位志愿者的临床和寄生虫反应,直到第28天。35例给予SP治疗的恶性疟原虫患者中,29例(83%)在治疗第28天出现复发性寄生虫血症(分别有14例、11例和4例出现RI、RII和RIII耐药)。在给予CQ的28例间日疟原虫病例中,有6例(21%)在第11天至第21天也观察到复发性寄生虫血症。虽然定量分析结果证实,耐cq的间日疟流行率较低,但在印度尼西亚,恶性疟原虫病例中耐SP的流行率是最高的。当对感染恶性疟原虫的志愿者体内存在的寄生虫进行基因分型时,在dhfr基因中发现与乙胺嘧啶抗性相关的突变频率很高,但没有证据表明dhps基因中存在对磺胺多辛抗性的选择。采用人落采集法对夜叮蚊进行调查,并对其进行孢子虫感染检测。在采集到的5种叮人按蚊中,巽他按蚊占优势(68%),唯一具有传染性的是167只雌蚊中2只(1.2%)携带间日疟孢子虫。由于大量无症状携带者、现有抗疟药物的有效性降低以及当地蚊子的叮咬和感染“率”,人们认为尼亚斯岛上人类感染疟疾的风险很高。sundaicus。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia
Abstract Nias Island, off the north-western coast of Sumatra, Indonesia, was one of the first locations in which chloroquine-resistant Plasmodium vivax malaria was reported. This resistance is of particular concern because its ancient megalithic culture and the outstanding surfing conditions make the island a popular tourist destination. International travel to and from the island could rapidly spread chloroquine-resistant strains of P. vivax across the planet. The threat posed by such strains, locally and internationally, has led to the routine and periodic re-assessment of the efficacy of antimalarial drugs and transmission potential on the island. Active case detection identified malaria in 124 (17%) of 710 local residents whereas passive case detection, at the central health clinic, confirmed malaria in 77 (44%) of 173 cases of presumed 'clinical malaria'. Informed consenting volunteers who had malarial parasitaemias were treated, according to the Indonesian Ministry of Health's recommendations, with sulfadoxine-pyrimethamine (SP) on day 0 (for P. falciparum) or with chloroquine (CQ) on days 0, 1 and 2 (for P. vivax). Each volunteer was then monitored for clinical and parasite response until day 28. Recurrent parasitaemia by day 28 treatment was seen in 29 (83%) of the 35 P. falciparum cases given SP (14, 11 and four cases showing RI, RII and RIII resistance, respectively). Recurrent parasitaemia was also observed, between day 11 and day 21, in six (21%) of the 28 P. vivax cases given CQ. Although the results of quantitative analysis confirmed only low prevalences of CQ-resistant P. vivax malaria, the prevalence of SP resistance among the P. falciparum cases was among the highest seen in Indonesia. When the parasites present in the volunteers with P. falciparum infections were genotyped, mutations associated with pyrimethamine resistance were found at high frequency in the dhfr gene but there was no evidence of selection for sulfadoxine resistance in the dhps gene. Night-biting mosquitoes were surveyed by human landing collections and tested for sporozoite infection. Among the five species of human-biting anophelines collected, Anopheles sundaicus was dominant (68%) and the only species found to be infective—two (1.2%) of 167 females being found carrying P. vivax sporozoites. The risk of malarial infection for humans on Nias was considered high because of the abundance of asymptomatic carriers, the reduced effectiveness of the available antimalarial drugs, and the biting and infection 'rates' of the local An. sundaicus.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信